Human Genome

Sequenom completes two high-resolution genome screens

Published in Gene Therapy Weekly, August 8th, 2002

Sequenom, Inc., (SQNM), a discovery genetics company, announced that it has completed 2 independent high-resolution genome screens of the human genome using a portfolio of 25,000 genetic markers.

The company's initial screen was for genes linked to age-related diseases, testing pooled samples of DNA from nearly 1500 individuals across the 25,000 markers. A subsequent screen compared DNA from more than 1000 melanoma patients and controls across the SNP assay set to identify genes linked to melanoma, a serious form of skin cancer.

Sequenom's genome-wide marker set, the largest of its kind available to date, consists of 25,000 gene-based single...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-08-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry